Exhibit 99.4 CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO REGULATION 240.24B-2B OF THE SECURITIES EXCHANGE ACT OF 1934. [*] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST AND IS FILED...And Supply Agreement and Sublicense • June 9th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJune 9th, 1999 Company Industry
Exhibit 99.4 CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO REGULATION 240.24B-2B OF THE SECURITIES EXCHANGE ACT OF 1934. [*] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST AND IS FILED...And Supply Agreement and Sublicense • March 19th, 1999 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 19th, 1999 Company Industry